Organization name

Phadia AB

SRN

SE-MF-000014170

Manufacturer status

Active

Primary placement in Sweden; available across 31 countries total.

Trade name

ImmunoCAP Allergen f431, Allergen component nGly m 5 Beta-conglycinin, Soy

UDI-DI code

Primary DI

The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.

07333066005768

Basic UDI-DI

Basic UDI-DI

The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.

7333066BUDI0017LX

Reference / catalog number

14-4990-01

Issuing entity

UDI issuing entities

Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.

GS1

Risk category

IVDR risk classes

IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.

IVDR Class B

Applicable legislation

IVDR [Regulation (EU) 2017/746 on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification

European Medical Device Nomenclature — the EU product classification assigned to this device.

• W01020202IMMUNOGLOBULIN E - SPECIFIC, MONOTEST/MONORESULT

• IVDR Class B medical devices in EUDAMED

No certificate specifically references this device's Basic UDI-DI.